SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-362406
Filing Date
2018-12-31
Accepted
2018-12-31 17:16:03
Documents
4
Period of Report
2018-12-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d672710d8k.htm 8-K 25618
2 EX-10.1 d672710dex101.htm EX-10.1 34597
3 EX-10.2 d672710dex102.htm EX-10.2 34433
4 GRAPHIC g672710img.jpg GRAPHIC 13117
  Complete submission text file 0001193125-18-362406.txt   114202
Mailing Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606
Business Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606 (813) 864-2559
HedgePath Pharmaceuticals, Inc. (Filer) CIK: 0001042418 (see all company filings)

IRS No.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13467 | Film No.: 181260310
SIC: 8731 Services-Commercial Physical & Biological Research